Functional DNA repair system analysis in haematopoietic progenitor cells using host cell reactivation

References

• Duker N. J. Chromosome breakage syndromes and cancer. Am J Med Genet 2002; 115: 125–9
   PubMedGoogle Scholar
• Emmert S., Leibeling D., Runger T. M. Syndromes with genetic instability: model diseases for (skin) cancerogenesis. J Dtsch Dermatol Ges 2006; 4: 721–31
   PubMedGoogle Scholar
• Das‐Gupta E. P., Seedhouse C. H., Russell N. H. DNA repair mechanisms and acute myeloblastic leukemia. Hematol Oncol 2000; 18: 99–110
   PubMed Web of Science ®Google Scholar
• Leibeling D., Laspe P., Emmert S. Nucleotide excision repair and cancer. J Mol Histol 2006; 37: 225–38
   PubMedGoogle Scholar
• Sung P. A., Libura J., Richardson C. Etoposide and illegitimate DNA double‐strand break repair in the generation of MLL translocations: new insights and new questions. DNA Repair (Amst) 2006; 5: 1109–18
   PubMedGoogle Scholar
• Worrillow L. J., Allan J. M. Deregulation of homologous recombination DNA repair in alkylating agent‐treated stem cell clones: a possible role in the aetiology of chemotherapy‐induced leukaemia. Oncogene 2006; 25: 1709–20
   PubMed Web of Science ®Google Scholar
• Seedhouse C., Faulkner R., Ashraf N., Das‐Gupta E., Russell N. Polymorphisms in genes involved in homologous recombination repair interact to increase the risk of developing acute myeloid leukemia. Clin Cancer Res 2004; 10: 2675–80
   PubMed Web of Science ®Google Scholar
• Gaymes T. J., Mufti G. J., Rassool F. V. Myeloid leukemias have increased activity of the nonhomologous end‐joining pathway and concomitant DNA misrepair that is dependent on the Ku70/86 heterodimer. Cancer Res 2002; 62: 2791–7
   PubMed Web of Science ®Google Scholar
• Ferguson D. O., Alt F. W. DNA double strand break repair and chromosomal translocation: lessons from animal models. Oncogene 2001; 20: 5572–9
   PubMedGoogle Scholar
• Protic‐Sabljic M., Kraemer K. H. One pyrimidine dimer inactivates expression of a transfected gene in xeroderma pigmentosum cells. Proc Natl Acad Sci USA 1985; 82: 6622–6
   PubMed Web of Science ®Google Scholar
• Qiao Y., Spitz M. R., Guo Z., Hadeyati M., Grossman L., Kraemer K. H., et al. Rapid assessment of repair of ultraviolet DNA damage with a modified host‐cell reactivation assay using a luciferase reporter gene and correlation with polymorphisms of DNA repair genes in normal human lymphocytes. Mutat Res 2002; 509: 165–74
   PubMed Web of Science ®Google Scholar
• Runger T. M., Emmert S., Schadendorf D., Diem C., Epe B., Hellfritsch D. Alterations of DNA repair in melanoma cell lines resistant to cisplatin, fotemustine, or etoposide. J Invest Dermatol 2000; 114: 34–9
   PubMedGoogle Scholar
• Slebos R. J., Taylor J. A. A novel host cell reactivation assay to assess homologous recombination capacity in human cancer cell lines. Biochem Biophys Res Commun 2001; 281: 212–19
   PubMedGoogle Scholar
• Emmert S., Kobayashi N., Khan S. G., Kraemer K. H. The xeroderma pigmentosum group C gene leads to selective repair of cyclobutane pyrimidine dimers rather than 6–4 photoproducts. Proc Natl Acad Sci USA 2000; 97: 2151–6
   PubMedGoogle Scholar
• Diem C., Runger T. M. Processing of three different types of DNA damage in cell lines of a cutaneous squamous cell carcinoma progression model. Carcinogenesis 1997; 18: 657–62
   PubMedGoogle Scholar
• Basecke J., Schwieger M., Griesinger F., Schiedlmeier B., Wulf G., Trumper L., et al. AML1/ETO promotes the maintenance of early hematopoietic progenitors in NOD/SCID mice but does not abrogate their lineage specific differentiation. Leuk Lymphoma 2005; 46: 265–72
   PubMed Web of Science ®Google Scholar
• Emmert S., Slor H., Busch D. B., Batko S., Albert R. B., Coleman D., et al. Relationship of neurologic degeneration to genotype in three xeroderma pigmentosum group G patients. J Invest Dermatol 2002; 118: 972–82
   PubMedGoogle Scholar
• Athas W. F., Hedayati M. A., Matanoski G. M., Farmer E. R., Grossman L. Development and field‐test validation of an assay for DNA repair in circulating human lymphocytes. Cancer Res 1991; 51: 5786–93
   PubMed Web of Science ®Google Scholar
• Koch K. S., Fletcher R. G., Grond M. P., Inyang A. I., Lu X. P., Brenner D. A., et al. Inactivation of plasmid reporter gene expression by one benzo(a)pyrene diol‐epoxide DNA adduct in adult rat hepatocytes. Cancer Res 1993; 53: 2279–86
   PubMedGoogle Scholar
• Fregeau C. J., Bleackley R. C. Factors influencing transient expression in cytotoxic T cells following DEAE dextran‐mediated gene transfer. Somat Cell Mol Genet 1991; 17: 239–57
   PubMedGoogle Scholar
• Allan J. M., Smith A. G., Wheatley K., Hills R. K., Travis L. B., Hill D. A., et al. Genetic variation in XPD predicts treatment outcome and risk of acute myeloid leukemia following chemotherapy. Blood 2004; 104: 3872–7
   PubMed Web of Science ®Google Scholar
• Gilliland D. G., Jordan C. T., Felix C. A. The molecular basis of leukemia. Hematology Am Soc Hematol Educ Program 2004; 80–97
   PubMedGoogle Scholar
• Jawad M., Seedhouse C. H., Russell N., Plumb M. Polymorphisms in human homeobox HLX1 and DNA repair RAD51 genes increase the risk of therapy‐related acute myeloid leukemia. Blood 2006; 108: 3916–18
   PubMed Web of Science ®Google Scholar
• Tischkowitz M. D., Hodgson S. V. Fanconi anaemia. J Med Genet 2003; 40: 1–10
   PubMed Web of Science ®Google Scholar
• Pedersen‐Bjergaard J., Christiansen D. H., Andersen M. K., Skovby F. Causality of myelodysplasia and acute myeloid leukemia and their genetic abnormalities. 2002; 16: 2177–84, Leukemia
   Google Scholar
• Das‐Gupta E. P., Seedhouse C. H., Russell N. H. Microsatellite instability occurs in defined subsets of patients with acute myeloblastic leukaemia. Br J Haematol 2001; 114: 307–12
   PubMed Web of Science ®Google Scholar